Terms: = Prostate cancer AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE AND Treatment
44 results:
1. [LncRNA RPL22P1-201 affects prostate cancer cell proliferation, cell cycle, and sensitivity to docetaxel by regulating miR-216b-5p expression].
Yang C; Xue JG
Zhonghua Nan Ke Xue; 2023 Oct; 29(10):881-887. PubMed ID: 38639656
[TBL] [Abstract] [Full Text] [Related]
2. The Hospitalization-Related Costs of Adverse Events for Novel Androgen Receptor Inhibitors in Non-Metastatic Castration-Resistant prostate cancer: An Indirect Comparison.
Shore N; Jiang S; Garcia-Horton V; Terasawa E; Steffen D; Chin A; Ayyagari R; Partridge J; Waldeck AR
Adv Ther; 2022 Nov; 39(11):5025-5042. PubMed ID: 36028656
[TBL] [Abstract] [Full Text] [Related]
3. cdk6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancer.
Chen X; Wu Y; Wang X; Xu C; Wang L; Jian J; Wu D; Wu G
Eur J Med Res; 2022 Jul; 27(1):105. PubMed ID: 35780240
[TBL] [Abstract] [Full Text] [Related]
4. Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration-resistant prostate cancer.
Bray AW; Duan R; Malalur P; Drusbosky LM; Gourdin TS; Hill EG; Lilly MB
Prostate; 2022 Sep; 82(13):1264-1272. PubMed ID: 35766303
[TBL] [Abstract] [Full Text] [Related]
5.
Moradi F; Duan H; Song H; Davidzon GA; Chung BI; Thong AEC; Loening AM; Ghanouni P; Sonn G; Iagaru A
J Nucl Med; 2022 Dec; 63(12):1822-1828. PubMed ID: 35512996
[TBL] [Abstract] [Full Text] [Related]
6. Role of solute carrier transporters SLC25A17 and SLC27A6 in acquired resistance to enzalutamide in castration-resistant prostate cancer.
Kushwaha PP; Verma SS; Shankar E; Lin S; Gupta S
Mol Carcinog; 2022 Apr; 61(4):397-407. PubMed ID: 34939235
[TBL] [Abstract] [Full Text] [Related]
7. Baicalin suppresses the cell cycle progression and proliferation of prostate cancer cells through the cdk6/FOXM1 axis.
Yu Z; Zhan C; Du H; Zhang L; Liang C; Zhang L
Mol Cell Biochem; 2020 Jun; 469(1-2):169-178. PubMed ID: 32385718
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive Analysis of AR Alterations in Circulating Tumor DNA from Patients with Advanced prostate cancer.
Ledet EM; Lilly MB; Sonpavde G; Lin E; Nussenzveig RH; Barata PC; Yandell M; Nagy RJ; Kiedrowski L; Agarwal N; Sartor O
Oncologist; 2020 Apr; 25(4):327-333. PubMed ID: 32297439
[TBL] [Abstract] [Full Text] [Related]
9. SOX7 is involved in polyphyllin D-induced G0/G1 cell cycle arrest through down-regulation of cyclin D1.
Zheng B; Wang G; Gao W; Wu Q; Zhu W; Weng G
Acta Pharm; 2020 Jun; 70(2):191-200. PubMed ID: 31955140
[TBL] [Abstract] [Full Text] [Related]
10. Long non-coding RNA AFAP1-AS1 promotes proliferation and invasion in prostate cancer via targeting miR-512-3p.
Wang K; Sun H; Sun T; Qu H; Xie Q; Lv H; Hu B
Gene; 2020 Feb; 726():144169. PubMed ID: 31669642
[TBL] [Abstract] [Full Text] [Related]
11. Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo.
Elango R; Vishnubalaji R; Manikandan M; Binhamdan SI; Siyal AA; Alshawakir YA; Alfayez M; Aldahmash A; Alajez NM
Sci Rep; 2019 Sep; 9(1):13696. PubMed ID: 31548560
[TBL] [Abstract] [Full Text] [Related]
12. Glucocorticoid receptor modulation decreases ER-positive breast cancer cell proliferation and suppresses wild-type and mutant ER chromatin association.
Tonsing-Carter E; Hernandez KM; Kim CR; Harkless RV; Oh A; Bowie KR; West-Szymanski DC; Betancourt-Ponce MA; Green BD; Lastra RR; Fleming GF; Chandarlapaty S; Conzen SD
Breast Cancer Res; 2019 Jul; 21(1):82. PubMed ID: 31340854
[TBL] [Abstract] [Full Text] [Related]
13. Analysis of the prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with definitive therapy.
Canter DJ; Freedland S; Rajamani S; Latsis M; Variano M; Halat S; Tward J; Cohen T; Stone S; Schlomm T; Bishoff J; Bardot S
Prostate Cancer Prostatic Dis; 2020 Mar; 23(1):102-107. PubMed ID: 31243337
[TBL] [Abstract] [Full Text] [Related]
14. Structure and function of FUS gene in prostate cancer.
Ghanbarpanah E; Kohanpour MA; Hosseini-Beheshti F; Yari L; Keshvari M
Bratisl Lek Listy; 2018; 119(10):660-663. PubMed ID: 30345776
[TBL] [Abstract] [Full Text] [Related]
15. Importance of non-regional lymph nodes in assigning risk in primary metastatic prostate cancer.
Ali A; Hoyle A; Mistry H; Clarke NW
BJU Int; 2019 Jan; 123(1):65-73. PubMed ID: 29777564
[TBL] [Abstract] [Full Text] [Related]
16. Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance.
Zhang J; Bu X; Wang H; Zhu Y; Geng Y; Nihira NT; Tan Y; Ci Y; Wu F; Dai X; Guo J; Huang YH; Fan C; Ren S; Sun Y; Freeman GJ; Sicinski P; Wei W
Nature; 2018 Jan; 553(7686):91-95. PubMed ID: 29160310
[TBL] [Abstract] [Full Text] [Related]
17. Bisphenol A and its analogues disrupt centrosome cycle and microtubule dynamics in prostate cancer.
Ho SM; Rao R; To S; Schoch E; Tarapore P
Endocr Relat Cancer; 2017 Feb; 24(2):83-96. PubMed ID: 27998958
[TBL] [Abstract] [Full Text] [Related]
18. MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells.
Erdmann K; Kaulke K; Rieger C; Salomo K; Wirth MP; Fuessel S
J Cancer Res Clin Oncol; 2016 Nov; 142(11):2249-61. PubMed ID: 27562865
[TBL] [Abstract] [Full Text] [Related]
19. [Solanine inhibits prostate cancer Du145 xenograft growth in nude mice by inducing cell cycle arrest in G1/S phase].
Zhong WF; Liu SP; Pan B; Tang ZF; Zhong JG; Zhou FJ
Nan Fang Yi Ke Da Xue Xue Bao; 2016 May; 36(5):665-70. PubMed ID: 27222182
[TBL] [Abstract] [Full Text] [Related]
20. A CDK4/6-Dependent Epigenetic Mechanism Protects cancer Cells from PML-induced Senescence.
Acevedo M; Vernier M; Mignacca L; Lessard F; Huot G; Moiseeva O; Bourdeau V; Ferbeyre G
Cancer Res; 2016 Jun; 76(11):3252-64. PubMed ID: 27206849
[TBL] [Abstract] [Full Text] [Related]
[Next]
